Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO)

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Albert-Marí, Asunción
• dc.contributor.author Jiménez-Pulido, Inmaculada
• dc.contributor.author San José-Ruiz, Begoña
• dc.contributor.author Conde Estévez, David
• dc.contributor.author Gil-Lemus, Mª Ángeles
• dc.contributor.author Cercós-Lletí, Ana Cristina
• dc.contributor.author Esteban-Mensua, M. Jesús
• dc.contributor.author Díaz-Carrasco, Mª Sacramento
• dc.date.accessioned 2022-11-21T07:36:14Z
• dc.date.available 2022-11-21T07:36:14Z
• dc.date.issued 2022
• dc.description Data de publicació electrónica: 26-04-2022
• dc.format.mimetype application/pdf
• dc.identifier.citation Albert-Marí A, Jiménez-Pulido I, José-Ruiz BS, Conde-Estévez D, Gil-Lemus MÁ, Cercós-Lletí AC, et al. Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO). J Oncol Pharm Pract. 2022 Apr 26: 10781552221091914. DOI: 10.1177/10781552221091914
• dc.identifier.doi http://dx.doi.org/10.1177/10781552221091914
• dc.identifier.issn 1078-1552
• dc.identifier.uri http://hdl.handle.net/10230/54921
• dc.language.iso eng
• dc.publisher SAGE Publications
• dc.rights Albert-Marí A, Jiménez-Pulido I, José-Ruiz BS, Conde-Estévez D, Gil-Lemus MÁ, Cercós-Lletí AC, et al. Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO), J Oncol Pharm Pract. 2022 Apr 26: 10781552221091914. Copyright © 2022. DOI: 10.1177/10781552221091914.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.other Medicaments antineoplàstics
• dc.subject.other Oncologia
• dc.title Antineoplastic extravasation management: consensus of the Spanish Oncology Pharmacy Group (GEDEFO)
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/acceptedVersion